Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection

View through CrossRef
Rhinovirus is a common cause of upper and lower respiratory tract infections in adults, especially among the elderly and immunocompromised. Nevertheless, its clinical characteristics and mortality risks have not been well described. A retrospective analysis on a prospective cohort was conducted in a single teaching hospital center over a one-year period. We compared adult patients hospitalized for pneumonia caused by rhinovirus infection with those hospitalized for influenza infection during the same period. All recruited patients were followed up for at least 3 months up to 15 months. Independent risk factors associated with mortality for rhinovirus infection were identified. Between 1 March 2014 and 28 February 2015, a total of 1946 patients were consecutively included for analysis. Of these, 728 patients were hospitalized for rhinovirus infection and 1218 patients were hospitalized for influenza infection. Significantly more rhinovirus patients were elderly home residents and had chronic lung diseases (p < 0.001), whereas more influenza patients had previous stroke (p = 0.02); otherwise, there were no differences in the Charlson comorbidity indexes between the two groups. More patients in the rhinovirus group developed pneumonia complications (p = 0.03), required oxygen therapy, and had a longer hospitalization period (p < 0.001), whereas more patients in the influenza virus group presented with fever (p < 0.001) and upper respiratory tract symptoms of cough and sore throat (p < 0.001), and developed cardiovascular complications (p < 0.001). The 30-day (p < 0.05), 90-day (p < 0.01), and 1-year (p < 0.01) mortality rate was significantly higher in the rhinovirus group than the influenza virus group. Intensive care unit admission (odds ratio (OR): 9.56; 95% confidence interval (C.I.) 2.17–42.18), elderly home residents (OR: 2.60; 95% C.I. 1.56–4.33), requirement of oxygen therapy during hospitalization (OR: 2.62; 95% C.I. 1.62–4.24), and hemoglobin level <13.3 g/dL upon admission (OR: 2.43; 95% C.I. 1.16–5.12) were independent risk factors associated with 1-year mortality in patients hospitalized for rhinovirus infection. Rhinovirus infection in the adults was associated with significantly higher mortality and longer hospitalization when compared with influenza virus infection. Institutionalized older adults were particularly at risk. More stringent infection control among health care workers in elderly homes could lower the infection rate before an effective vaccine and antiviral become available.
Title: Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection
Description:
Rhinovirus is a common cause of upper and lower respiratory tract infections in adults, especially among the elderly and immunocompromised.
Nevertheless, its clinical characteristics and mortality risks have not been well described.
A retrospective analysis on a prospective cohort was conducted in a single teaching hospital center over a one-year period.
We compared adult patients hospitalized for pneumonia caused by rhinovirus infection with those hospitalized for influenza infection during the same period.
All recruited patients were followed up for at least 3 months up to 15 months.
Independent risk factors associated with mortality for rhinovirus infection were identified.
Between 1 March 2014 and 28 February 2015, a total of 1946 patients were consecutively included for analysis.
Of these, 728 patients were hospitalized for rhinovirus infection and 1218 patients were hospitalized for influenza infection.
Significantly more rhinovirus patients were elderly home residents and had chronic lung diseases (p < 0.
001), whereas more influenza patients had previous stroke (p = 0.
02); otherwise, there were no differences in the Charlson comorbidity indexes between the two groups.
More patients in the rhinovirus group developed pneumonia complications (p = 0.
03), required oxygen therapy, and had a longer hospitalization period (p < 0.
001), whereas more patients in the influenza virus group presented with fever (p < 0.
001) and upper respiratory tract symptoms of cough and sore throat (p < 0.
001), and developed cardiovascular complications (p < 0.
001).
The 30-day (p < 0.
05), 90-day (p < 0.
01), and 1-year (p < 0.
01) mortality rate was significantly higher in the rhinovirus group than the influenza virus group.
Intensive care unit admission (odds ratio (OR): 9.
56; 95% confidence interval (C.
I.
) 2.
17–42.
18), elderly home residents (OR: 2.
60; 95% C.
I.
1.
56–4.
33), requirement of oxygen therapy during hospitalization (OR: 2.
62; 95% C.
I.
1.
62–4.
24), and hemoglobin level <13.
3 g/dL upon admission (OR: 2.
43; 95% C.
I.
1.
16–5.
12) were independent risk factors associated with 1-year mortality in patients hospitalized for rhinovirus infection.
Rhinovirus infection in the adults was associated with significantly higher mortality and longer hospitalization when compared with influenza virus infection.
Institutionalized older adults were particularly at risk.
More stringent infection control among health care workers in elderly homes could lower the infection rate before an effective vaccine and antiviral become available.

Related Results

U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: Borders‐Hemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Pudilan xiaoyan oral liquid (PDL) inhibit the replication of influenza A virus through regulating TLR3/MyD88 signaling pathway
Pudilan xiaoyan oral liquid (PDL) inhibit the replication of influenza A virus through regulating TLR3/MyD88 signaling pathway
Abstract Background Pudilan Xiaoyan Oral Liquid (PDL) as a famous Chinese patent medicine has been widely used for treating upper respiratory tract infection. However, the...
Isolation and Characterization of Influenza Virus B (Lee Strain)
Isolation and Characterization of Influenza Virus B (Lee Strain)
Summary A particulate component possessing the biological properties of the influenza virus B (Lee strain), as determined by chicken red blood cell agglutination, pr...
Coverage and Influencing factors of Influenza Vaccination among the elderly in Minhang District, Shanghai
Coverage and Influencing factors of Influenza Vaccination among the elderly in Minhang District, Shanghai
Objectives: To describe the influenza vaccination coverage and identify its influencing factors, and understand the reasons for not receiving influenza vaccination among the elderl...
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV- 2), a novel betacoronavirus, is the etiological agent of coronavirus disease 2019 (COVID-19), a global health threat. The ...

Back to Top